Literature DB >> 34074458

The link between vitamin D and COVID-19.

Daniel M O Campos1, Edilson D Silva1, Umberto L Fulco1, Jonas I N Oliveira2.   

Abstract

Entities:  

Year:  2021        PMID: 34074458      PMCID: PMC8163559          DOI: 10.1016/j.cct.2021.106395

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


× No keyword cloud information.
  10 in total

1.  The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial.

Authors:  M D Kearns; J N G Binongo; D Watson; J A Alvarez; D Lodin; T R Ziegler; V Tangpricha
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

Review 2.  Antibacterial effects of vitamin D.

Authors:  Martin Hewison
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

3.  Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.

Authors:  Robert P Heaney; K Michael Davies; Tai C Chen; Michael F Holick; M Janet Barger-Lux
Journal:  Am J Clin Nutr       Date:  2003-01       Impact factor: 7.045

4.  Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study).

Authors:  Pankaj Malhotra; Ashu Rastogi; Anil Bhansali; Niranjan Khare; Vikas Suri; Narayana Yaddanapudi; Naresh Sachdeva; G D Puri
Journal:  Postgrad Med J       Date:  2020-11-12       Impact factor: 2.401

Review 5.  Effect of Vitamin D3 Supplementation on Respiratory Tract Infections in Healthy Individuals: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Danielle Vuichard Gysin; Dyda Dao; Christian Michael Gysin; Lyubov Lytvyn; Mark Loeb
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 6.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.

Authors:  Adrian R Martineau; David A Jolliffe; Richard L Hooper; Lauren Greenberg; John F Aloia; Peter Bergman; Gal Dubnov-Raz; Susanna Esposito; Davaasambuu Ganmaa; Adit A Ginde; Emma C Goodall; Cameron C Grant; Christopher J Griffiths; Wim Janssens; Ilkka Laaksi; Semira Manaseki-Holland; David Mauger; David R Murdoch; Rachel Neale; Judy R Rees; Steve Simpson; Iwona Stelmach; Geeta Trilok Kumar; Mitsuyoshi Urashima; Carlos A Camargo
Journal:  BMJ       Date:  2017-02-15

7.  SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.

Authors:  Harvey W Kaufman; Justin K Niles; Martin H Kroll; Caixia Bi; Michael F Holick
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

8.  The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design.

Authors:  Rui Wang; Victor DeGruttola; Quanhong Lei; Kenneth H Mayer; Susan Redline; Aditi Hazra; Samia Mora; Walter C Willett; Davaasambuu Ganmaa; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2020-10-10       Impact factor: 2.226

9.  25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2.

Authors:  Antonio D'Avolio; Valeria Avataneo; Alessandra Manca; Jessica Cusato; Amedeo De Nicolò; Renzo Lucchini; Franco Keller; Marco Cantù
Journal:  Nutrients       Date:  2020-05-09       Impact factor: 5.717

10.  COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.

Authors:  Alfonso Fasano; Emanuele Cereda; Michela Barichella; Erica Cassani; Valentina Ferri; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  Mov Disord       Date:  2020-06-26       Impact factor: 9.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.